2022 Annual Meeting | C39 - Critical Care Consultations for Neurohospitalists
Program Materials Program Evaluations
07:00 AM - 09:00 AM PDT | Speaker |
walk in slides
Jana Wold, MD |
07:05 AM - 07:40 AM PDT | Speaker |
The Dark Side of Emerging Cancer Therapies
Alexandra Muccilli, MD |
07:40 AM - 08:15 AM PDT | Speaker |
Delirium Management for the Neurohospitalist
Sara LaHue, MD |
08:15 AM - 08:50 AM PDT | Speaker |
Updates in Prognostication and Management of Anoxic Brain Injury
Jana Wold, MD |
08:50 AM - 09:00 AM PDT | Speaker |
Discussion & Questions and Answers
Jana Wold, MD |
Jana Wold, MD | Dr. Wold has nothing to disclose. |
Alexandra Muccilli, MD | Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Muccilli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. |
Sara LaHue, MD | The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. The institution of Dr. LaHue has received research support from Doris Duke Foundation . Dr. LaHue has received publishing royalties from a publication relating to health care. |